The Arts Council of England today announced its funding plans for the years 2012-15, released in the shadow of a 29.6% reduction in government funding. Inevitably the big story is cuts, but there is plenty of good news for London theatres. Winners include the Arcola Theatre (above), set to receive an 82.1% increase in funding; Artangel (19.3%); the Barbican (108.7%); the Broadway Barking (52.8%); Fevered Sleep (16.7%); Fuel (203.5%); Greenwich and Docklands Festivals (33.4%); Ockham’s Razor (173.2%); LIFT (17.1%); Punchdrunk (141%); Ridiculusmus (27.7%); Stratford Circus (554.8%) and Told By An Idiot (26.9%). There’s also good news some of our favourite new companies who join the Arts Council portfolio as NPOs – we’re particularly happy for Coney and the Clod Ensemble.
However, there’s grim news elsewhere. Many major subsidised London theatres and companies – including the Bush, BAC, the NYT – face a freeze in funding, which, adjusted for inflation, amounts to an 11% decline in funding by 2015. Steep cuts have hit the Almeida Theatre (down 39%) and the ICA (down 42.5 %), and even the National Theatre’s vast subsidy takes a knock (14.9 %). More worrying, though, are the companies who have lost their funding entirely. An offical list is not going to be been made available, but so far word is in that veteran theatre company Shared Experience has lost all funding, as has Hammersmith’s Riverside Studios.
To see what’s currently playing in the capital, see Time Out London theatre listings.